Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

Infectious Diseases

Infectious diseases caused by viral or bacterial pathogens are a major cause of death and morbidity worldwide and constitute an ever growing medical need. We are focusing on discovery, research and development of new anti-infective agents, targeting both the pathogen as well as the host immune defences. In this, we build on an industry-leading technology platform and on a rich legacy of research in this field, which produced some outstanding therapeutics in hepatitis B, influenza and multi-drug resistant bacterial infections.

Partnering opportunities we are looking for:

  • Hepatitis B
  • Respiratory Viruses
  • Multidrug-resistant, Gram-negative Bacterial Infections

Example partnerships

Dicerna – research collaboration and licensing agreement to develop siRNA therapies for the treatment of chronic hepatitis B virus (HBV) infection

Your dedicated partnering leads in Infectious Diseases


Patrick Schleck, Head of Immunology & Infectious Diseases, Pharma Partnering


Karl Yen, Search & Evaluation Lead Immunology and Infectious Diseases, Pharma Partnering